One year (August 1, 2028 – July 31, 2029 for the current cycle)
Hands-on
Unclear — confirm privileges
Latest source audit
3 Oct 2026
Duration · publishedOne year (August 1, 2028 – July 31, 2029 for the current cycle)
Clinical exposureFellow focuses solely on orthopaedic oncology patients (no general orthopaedic cases), rotating with core adult musculoskeletal oncology faculty at The James Cancer Hospital, with paediatric musculoskeletal oncology exposure at Nationwide Children's Hospital and interdisciplinary training in radiation and medical oncology. Weekly tumour board, indications conference and journal club, monthly OSU/Nationwide Children's/OSU Veterinary Medicine sarcoma journal club, plus departmental M&M, quality and visiting-professor programmes.
Participation levelClinical participation and hands-on restrictions must be confirmed directly with the host.
INTERNATIONAL APPLICANT CHECK
What the official evidence currently supports
Decision-critical fields are separated into confirmed facts, partial information and points requiring direct confirmation.
≈Partially published
International applicant eligibility
Non-US citizens need permanent resident status with work authorisation, or J-1 eligibility through ECFMG (DS-2019 required before start), or H-1B in limited cases (F-1 students at LCME/AOA US schools or trainees already on H-1B; GME office approval needed before ranking/offer).
✓Published by official source
Required training level
Graduate of an LCME-accredited (US/Canada) or AOA-accredited (US) medical school, or IMG with valid ECFMG certificate (or full unrestricted Ohio licence) or Fifth Pathway · All prior clinical education in an ACGME, AOA, ACGME-I (Advanced Specialty) or RCPSC/CFPC-accredited residency (exceptional-IMG pathway via GMEC approval possible) · USMLE Step 1 and Step 2 completed before appointment · Eligible for an Ohio State Medical Board training certificate or permanent medical licence · Must obtain limited staff privileges at OSU Hospital and sign the Limited Staff Agreement
✓Published by official source
Programme classification
Clinical or combined training pathway; exact duties remain appointment-specific.
?Confirm directly with host
Hands-on restrictions
Hands-on participation and operative restrictions are not explicitly published.
≈Partially published
Medical registration
Ohio State Medical Board training certificate or permanent Ohio medical licence (application acknowledgement or licence required before appointment)
?Confirm directly with host
Licensing examinations
Any examination requirement must be confirmed with the relevant regulator and host.
—Not published
Language requirements
No formal language requirement is published by the cited source.
≈Partially published
Visa or work authorisation
J-1 via ECFMG Exchange Visitor Sponsorship Program; H-1B only for eligible F-1 US-school graduates or current H-1B trainees, with prior GME office approval
✓Published by official source
Funding availability
House officer salaries 2025–2026: PGY6 $80,478; PGY7 $81,153
DATA QUALITY & AVAILABILITY
93% of core application fields verified
Checked 3 Oct 2026. Next scheduled editorial review: 2027-04-01. Every unresolved field keeps its exact evidence state—unpublished, not yet researched, historical, conflicting, inaccessible or not applicable—so an absence is never converted into a fact.
✓ programme title✓ institution / department✓ city and country✓ programme classification✓ subspecialty✓ current status evidence✓ duration✓ positions✓ commencement / intake✓ funding✓ benefits✓ eligibility✓ international eligibility✓ registration✓ visa / work authorisation✓ deadline✓ application process✓ required documents✓ application portal✓ official contact✓ faculty✓ verified faculty photograph✓ verified institution logo✓ official source✓ institutional source✓ accreditation / organisation source✓ verification date— accommodation / relocation · queued for source review— Language requirement not published · queued for source review
APPLICATION TIMELINE & CONTACT
Plan the application
Application deadlineOctober 5, 2026
Commencing dateAugust 1, 2028
Application route / cycleSF Match; interview invitations week of November 2; in-person interviews January 28, 2027 in Columbus, Ohio; for the fellowship starting August 1, 2028
Official contactJulia Panzo, Director of Graduate Medical Education – Department of Orthopaedics (also Gabby Ford, GME Specialist/Administrative Assistant, gabrielle.ford@osumc.edu)Julia.Panzo@osumc.edu614-293-6194
Deadlines and intake dates can change between cycles. The data-quality ledger above explicitly labels application fields that the cited official source does not publish.
ELIGIBILITY & REQUIREMENTS
Published entry requirements
Clinical / academic eligibility
Graduate of an LCME-accredited (US/Canada) or AOA-accredited (US) medical school, or IMG with valid ECFMG certificate (or full unrestricted Ohio licence) or Fifth Pathway
All prior clinical education in an ACGME, AOA, ACGME-I (Advanced Specialty) or RCPSC/CFPC-accredited residency (exceptional-IMG pathway via GMEC approval possible)
USMLE Step 1 and Step 2 completed before appointment
Eligible for an Ohio State Medical Board training certificate or permanent medical licence
Must obtain limited staff privileges at OSU Hospital and sign the Limited Staff Agreement
Registration, licence & examinations
Ohio State Medical Board training certificate or permanent Ohio medical licence (application acknowledgement or licence required before appointment)
Visa / work authorisation
J-1 via ECFMG Exchange Visitor Sponsorship Program; H-1B only for eligible F-1 US-school graduates or current H-1B trainees, with prior GME office approval
Application documents
SF Match Fellowship Application including personal statement
CV
Letter of Good Standing (Status Report Form)
Three letters of recommendation
USMLE score report
Licensing, visa and document rules depend on the individual programme and application cycle. OrthoFellow does not infer USMLE, AHPRA, ECFMG, recommendation-letter or visa requirements from the country alone.
PROGRAM OVERVIEW
What this program offers
A one-year ACGME-accredited orthopaedic oncology fellowship in which the fellow treats only orthopaedic oncology patients across adult and paediatric settings, with a required publication and presentation at the Mallory-Coleman Research Day.
BENEFITS & SUPPORT
Published benefits and support
Three weeks paid vacation; one week paid professional leave for a national or international conference with reimbursement of attendance; Ohio State University benefits (OSU Health Plan)
Benefits may depend on appointment type, training level, visa status and the active academic year. OrthoFellow keeps stipend and benefits separate so a salary figure is not mistaken for the full package.
HOST INSTITUTION
About The Ohio State University Wexner Medical Center / College of Medicine, Department of Orthopaedics
Based at The James Cancer Hospital (OSUCCC – James) of The Ohio State University Wexner Medical Center, with paediatric rotations at Nationwide Children's Hospital.
Program Director, Musculoskeletal Oncology Fellowship; Assistant Professor of Clinical OrthopaedicsOfficial profile & photo verified
Current position
Fellowship supervisor / program leadership
Affiliation
The Ohio State University Wexner Medical Center / OSUCCC – James
Clinical focus
Musculoskeletal Oncology training and clinical practice
Qualifications
Not published on the cited profile
John Alexander is listed in the cited programme evidence as program director, musculoskeletal oncology fellowship; assistant professor of clinical orthopaedics for Musculoskeletal Oncology Fellowship Program. The verified individual profile describes a focus in Musculoskeletal Oncology training and clinical practice. This association does not by itself confirm personal supervision, operative privileges or availability for a future intake.
John Alexander is listed by the official programme source as program director, musculoskeletal oncology fellowship; assistant professor of clinical orthopaedics. A separate individual short CV has not yet been verified by OrthoFellow.
Professor of Orthopaedics; Director, Division of Orthopaedic Oncology; Medical Director, Sarcoma Services, The JamesOfficial profile & photo verified
Current position
Teaching faculty / co-leadership
Affiliation
The Ohio State University Wexner Medical Center / OSUCCC – James
Clinical focus
Musculoskeletal Oncology training and clinical practice
Qualifications
Not published on the cited profile
Joel Mayerson is listed in the cited programme evidence as professor of orthopaedics; director, division of orthopaedic oncology; medical director, sarcoma services, the james for Musculoskeletal Oncology Fellowship Program. The verified individual profile describes a focus in Musculoskeletal Oncology training and clinical practice. This association does not by itself confirm personal supervision, operative privileges or availability for a future intake.
Joel Mayerson is listed by the official programme source as professor of orthopaedics; director, division of orthopaedic oncology; medical director, sarcoma services, the james. A separate individual short CV has not yet been verified by OrthoFellow.
Division of Musculoskeletal OncologyOfficial program roster
Current position
Teaching faculty / co-leadership
Affiliation
The Ohio State University Wexner Medical Center
Clinical focus
Musculoskeletal Oncology training and clinical practice
Qualifications
Not published on the cited profile
Carl Quinion is listed in the cited programme evidence as division of musculoskeletal oncology for Musculoskeletal Oncology Fellowship Program. The verified individual profile describes a focus in Musculoskeletal Oncology training and clinical practice. This association does not by itself confirm personal supervision, operative privileges or availability for a future intake.
Carl Quinion is listed by the official programme source as division of musculoskeletal oncology. A separate individual short CV has not yet been verified by OrthoFellow.
TS
Faculty: Thomas Scharschmidt
Director, Center for Musculoskeletal Oncology; Fellowship Director, Pediatric Orthopedic Musculoskeletal Oncology, Nationwide Children's Hospital; Professor of Orthopedic SurgeryOfficial program roster
Current position
Teaching faculty / co-leadership
Affiliation
Nationwide Children's Hospital / The Ohio State University Wexner Medical Center
Clinical focus
Musculoskeletal Oncology training and clinical practice
Qualifications
Not published on the cited profile
Thomas Scharschmidt is listed in the cited programme evidence as director, center for musculoskeletal oncology; fellowship director, pediatric orthopedic musculoskeletal oncology, nationwide children's hospital; professor of orthopedic surgery for Musculoskeletal Oncology Fellowship Program. The verified individual profile describes a focus in Musculoskeletal Oncology training and clinical practice. This association does not by itself confirm personal supervision, operative privileges or availability for a future intake.
Thomas Scharschmidt is listed by the official programme source as director, center for musculoskeletal oncology; fellowship director, pediatric orthopedic musculoskeletal oncology, nationwide children's hospital; professor of orthopedic surgery. A separate individual short CV has not yet been verified by OrthoFellow.
Names and fellowship roles come from the cited programme source. A green “individual profile verified” label means the position, qualifications and biography were also checked against an official personal or institutional profile. OrthoFellow displays a portrait only when it can be tied to an official profile or faculty source; otherwise the host institution brandmark is shown, with initials retained only when neither image is available. Faculty rosters may change.
◎
INTERNATIONAL APPLICANTS
Published international eligibility information
Non-US citizens need permanent resident status with work authorisation, or J-1 eligibility through ECFMG (DS-2019 required before start), or H-1B in limited cases (F-1 students at LCME/AOA US schools or trainees already on H-1B; GME office approval needed before ranking/offer).
This note is shown only when the official source publishes information relevant to overseas applicants. Applicants should confirm licensing and visa eligibility directly with the host.
The University of Texas MD Anderson Cancer Center Department of Orthopaedic Oncology
Houston, Texas, United States · 1-year Clinical Fellowship, with an optional second-year Advanced Musculoskeletal Oncology Fellowship (clinical, surgery and research) after completing the clinical yearView program profile →
